1
|
Sanchez C, El Radi H, Gay N, Cailletaud J, Grollier K, Thomas F, Gonthiez T. Synthetic modeling: A cell-free approach for faster implementation of Raman spectroscopy in cell culture. Biotechnol Prog 2025:e70018. [PMID: 40126075 DOI: 10.1002/btpr.70018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2024] [Revised: 02/03/2025] [Accepted: 02/05/2025] [Indexed: 03/25/2025]
Abstract
Monitoring cell culture is crucial for gaining a deeper understanding of processes and ensuring the production of safe and high-quality products. The capability to measure in real time several parameters of interest can be achieved with Raman spectroscopy. However, before using Raman spectroscopy to monitor a specific process, a calibration phase is required to develop chemometric models that correlate Raman spectra with the target parameters. It is mandatory to conduct this phase with multiple batches to build robust models that account for biological variability. This model building phase can be time-consuming and require a lot of resources. The industry is actively seeking solutions to simplify and expedite this step without compromising accuracy. Moreover, the current approach has limitations regarding changing cell culture media, celllines, or process scale. The novel synthetic model approach provides a significant gain of time and resources for the calibration phase, which is reduced to just a few days. The methodology involves using cell-free samples of cell culture media that are spiked with various concentrations of target compounds. The results indicate that the innovative approach enables accurate measurement for glucose and lactate parameters in real process conditions comparable to a standard modeling methodology.
Collapse
Affiliation(s)
- Célia Sanchez
- Millipore SAS (an affiliate of Merck KGaA, Darmstadt, Germany), Meylan, France
| | - Hadi El Radi
- Millipore SAS (an affiliate of Merck KGaA, Darmstadt, Germany), Meylan, France
| | - Nathan Gay
- Millipore SAS (an affiliate of Merck KGaA, Darmstadt, Germany), Meylan, France
| | - Johan Cailletaud
- Millipore SAS (an affiliate of Merck KGaA, Darmstadt, Germany), Meylan, France
| | - Kévin Grollier
- Millipore SAS (an affiliate of Merck KGaA, Darmstadt, Germany), Meylan, France
| | - Fabrice Thomas
- Millipore SAS (an affiliate of Merck KGaA, Darmstadt, Germany), Meylan, France
| | - Thierry Gonthiez
- Millipore SAS (an affiliate of Merck KGaA, Darmstadt, Germany), Meylan, France
| |
Collapse
|
2
|
Costa MHG, Carrondo I, Isidro IA, Serra M. Harnessing Raman spectroscopy for cell therapy bioprocessing. Biotechnol Adv 2024; 77:108472. [PMID: 39490752 DOI: 10.1016/j.biotechadv.2024.108472] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2024] [Revised: 10/06/2024] [Accepted: 10/23/2024] [Indexed: 11/05/2024]
Abstract
Cell therapy manufacturing requires precise monitoring of critical parameters to ensure product quality, consistency and to facilitate the implementation of cost-effective processes. While conventional analytical methods offer limited real-time insights, integration of process analytical technology tools such as Raman spectroscopy in bioprocessing has the potential to drive efficiency and reliability during the manufacture of cell-based therapies while meeting stringent regulatory requirements. The non-destructive nature of Raman spectroscopy, combined with its ability to be integrated on-line with scalable platforms, allows for continuous data acquisition, enabling real-time correlations between process parameters and critical quality attributes. Herein, we review the role of Raman spectroscopy in cell therapy bioprocessing and discuss how simultaneous measurement of distinct parameters and attributes, such as cell density, viability, metabolites and cell identity biomarkers can streamline on-line monitoring and facilitate adaptive process control. This, in turn, enhances productivity and mitigates process-related risks. We focus on recent advances integrating Raman spectroscopy across various manufacturing stages, from optimizing culture media feeds to monitoring bioprocess dynamics, covering downstream applications such as detection of co-isolated contaminating cells, cryopreservation, and quality control of the drug product. Finally, we discuss the potential of Raman spectroscopy to revolutionize current practices and accelerate the development of advanced therapy medicinal products.
Collapse
Affiliation(s)
- Marta H G Costa
- iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901 Oeiras, Portugal; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal.
| | - Inês Carrondo
- iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901 Oeiras, Portugal; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal
| | - Inês A Isidro
- iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901 Oeiras, Portugal; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal
| | - Margarida Serra
- iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901 Oeiras, Portugal; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal
| |
Collapse
|
3
|
Zhang Z, Lang Z, Chen G, Zhou H, Zhou W. Development of generic metabolic Raman calibration models using solution titration in aqueous phase and data augmentation for in-line cell culture analysis. Biotechnol Bioeng 2024; 121:2193-2204. [PMID: 38639160 DOI: 10.1002/bit.28717] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Revised: 02/29/2024] [Accepted: 04/08/2024] [Indexed: 04/20/2024]
Abstract
This study presents a novel approach for developing generic metabolic Raman calibration models for in-line cell culture analysis using glucose and lactate stock solution titration in an aqueous phase and data augmentation techniques. First, a successful set-up of the titration method was achieved by adding glucose or lactate solution at several different constant rates into the aqueous phase of a bench-top bioreactor. Subsequently, the in-line glucose and lactate concentration were calculated and interpolated based on the rate of glucose and lactate addition, enabling data augmentation and enhancing the robustness of the metabolic calibration model. Nine different combinations of spectra pretreatment, wavenumber range selection, and number of latent variables were evaluated and optimized using aqueous titration data as training set and a historical cell culture data set as validation and prediction set. Finally, Raman spectroscopy data collected from 11 historical cell culture batches (spanning four culture modes and scales ranging from 3 to 200 L) were utilized to predict the corresponding glucose and lactate values. The results demonstrated a high prediction accuracy, with an average root mean square errors of prediction of 0.65 g/L for glucose, and 0.48 g/L for lactate. This innovative method establishes a generic metabolic calibration model, and its applicability can be extended to other metabolites, reducing the cost of deploying real-time cell culture monitoring using Raman spectroscopy in bioprocesses.
Collapse
Affiliation(s)
- Zhijun Zhang
- Cell Culture Process Development (CCPD), WuXi Biologics, Shanghai, China
| | - Zhe Lang
- Cell Culture Process Development (CCPD), WuXi Biologics, Shanghai, China
| | - Gong Chen
- Cell Culture Process Development (CCPD), WuXi Biologics, Shanghai, China
| | - Hang Zhou
- Cell Culture Process Development (CCPD), WuXi Biologics, Shanghai, China
| | - Weichang Zhou
- Global Biologics Development and Operations (GBDO), WuXi Biologics, Shanghai, China
| |
Collapse
|
4
|
Dong X, Yan X, Wan Y, Gao D, Jiao J, Wang H, Qu H. Enhancing real-time cell culture monitoring: Automated Raman model optimization with Taguchi method. Biotechnol Bioeng 2024; 121:1831-1845. [PMID: 38454569 DOI: 10.1002/bit.28688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2023] [Revised: 11/18/2023] [Accepted: 02/20/2024] [Indexed: 03/09/2024]
Abstract
Raman spectroscopy has found widespread usage in monitoring cell culture processes both in research and practical applications. However, commonly, preprocessing methods, spectral regions, and modeling parameters have been chosen based on experience or trial-and-error strategies. These choices can significantly impact the performance of the models. There is an urgent need for a simple, effective, and automated approach to determine a suitable procedure for constructing accurate models. This paper introduces the adoption of a design of experiment (DoE) method to optimize partial least squares models for measuring the concentration of different components in cell culture bioreactors. The experimental implementation utilized the orthogonal test table L25(56). Within this framework, five factors were identified as control variables for the DoE method: the window width of Savitzky-Golay smoothing, the baseline correction method, the order of preprocessing steps, spectral regions, and the number of latent variables. The evaluation method for the model was considered as a factor subject to noise. The optimal combination of levels was determined through the signal-to-noise ratio response table employing Taguchi analysis. The effectiveness of this approach was validated through two cases, involving different cultivation scales, different Raman spectrometers, and different analytical components. The results consistently demonstrated that the proposed approach closely approximated the global optimum, regardless of data set size, predictive components, or the brand of Raman spectrometer. The performance of models recommended by the DoE strategy consistently surpassed those built using raw data, underscoring the reliability of models generated through this approach. When compared to exhaustive all-combination experiments, the DoE approach significantly reduces calculation times, making it highly practical for the implementation of Raman spectroscopy in bioprocess monitoring.
Collapse
Affiliation(s)
- Xiaoxiao Dong
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Xu Yan
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Yuxiang Wan
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Dong Gao
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Jingyu Jiao
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Haibin Wang
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Haibin Qu
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| |
Collapse
|
5
|
Wan B, Patel M, Zhou G, Olma M, Bieri M, Mueller M, Appiah-Amponsah E, Patel B, Jayapal K. Robust platform for inline Raman monitoring and control of perfusion cell culture. Biotechnol Bioeng 2024; 121:1688-1701. [PMID: 38393313 DOI: 10.1002/bit.28680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Revised: 01/23/2024] [Accepted: 02/12/2024] [Indexed: 02/25/2024]
Abstract
Perfusion cell culture has been gaining increasing popularity for biologics manufacturing due to benefits such as smaller footprint, increased productivity, consistent product quality and manufacturing flexibility, cost savings, and so forth. Process Analytics Technologies tools are highly desirable for effective monitoring and control of long-running perfusion processes. Raman has been widely investigated for monitoring and control of traditional fed batch cell culture process. However, implementation of Raman for perfusion cell culture has been very limited mainly due to challenges with high-cell density and long running times during perfusion which cause extremely high fluorescence interference to Raman spectra and consequently it is exceedingly difficult to develop robust chemometrics models. In this work, a platform based on Raman measurement of permeate has been proposed for effective analysis of perfusion process. It has been demonstrated that this platform can effectively circumvent the fluorescence interference issue while providing rich and timely information about perfusion dynamics to enable efficient process monitoring and robust bioreactor feed control. With the highly consistent spectral data from cell-free sample matrix, development of chemometrics models can be greatly facilitated. Based on this platform, Raman models have been developed for good measurement of several analytes including glucose, lactate, glutamine, glutamate, and permeate titer. Performance of Raman models developed this way has been systematically evaluated and the models have shown good robustness against changes in perfusion scale and variations in permeate flowrate; thus models developed from small lab scale can be directly transferred for implementation in much larger scale of perfusion. With demonstrated robustness, this platform provides a reliable approach for automated glucose feed control in perfusion bioreactors. Glucose model developed from small lab scale has been successfully implemented for automated continuous glucose feed control of perfusion cell culture at much larger scale.
Collapse
Affiliation(s)
- Boyong Wan
- Analytical Research & Development, Merck & Co. Inc., Kenilworth, New Jersey, USA
| | - Misaal Patel
- Bioprocess Research & Development, Merck & Co. Inc., Kenilworth, New Jersey, USA
| | - George Zhou
- Global Vaccine and Biologics Commercialization, Merck & Co. Inc., Kenilworth, New Jersey, USA
| | - Michael Olma
- Analytical Research & Development, Werthenstein Biopharma GmbH, MSD, Werthenstein, Switzerland
| | - Marco Bieri
- Analytical Research & Development, Werthenstein Biopharma GmbH, MSD, Werthenstein, Switzerland
| | - Marvin Mueller
- Analytical Research & Development, Werthenstein Biopharma GmbH, MSD, Werthenstein, Switzerland
| | | | - Bhumit Patel
- Analytical Research & Development, Merck & Co. Inc., Kenilworth, New Jersey, USA
| | - Karthik Jayapal
- Bioprocess Research & Development, Merck & Co. Inc., Kenilworth, New Jersey, USA
| |
Collapse
|
6
|
Yan X, Dong X, Wan Y, Gao D, Chen Z, Zhang Y, Zheng Z, Chen K, Jiao J, Sun Y, He Z, Nie L, Fan X, Wang H, Qu H. Development of an in-line Raman analytical method for commercial-scale CHO cell culture process monitoring: Influence of measurement channels and batch number on model performance. Biotechnol J 2024; 19:e2300395. [PMID: 38180295 DOI: 10.1002/biot.202300395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Revised: 12/03/2023] [Accepted: 12/22/2023] [Indexed: 01/06/2024]
Abstract
The mammalian cell culture process is a key step in commercial therapeutic protein production and needs to be monitored and controlled due to its complexity. Raman spectroscopy has been reported for cell culture process monitoring by analysis of many important parameters. However, studies on in-line Raman monitoring of the cell culture process were mainly conducted on small or pilot scale. Developing in-line Raman analytical methods for commercial-scale cell culture process monitoring is more challenging. In this study, an in-line Raman analytical method was developed for monitoring glucose, lactate, and viable cell density (VCD) in the Chinese hamster ovary (CHO) cell culture process during commercial production of biosimilar adalimumab (1500 L). The influence of different Raman measurement channels was considered to determine whether to merge data from different channels for model development. Raman calibration models were developed and optimized, with minimum root mean square error of prediction of 0.22 g L-1 for glucose in the range of 1.66-3.53 g L-1 , 0.08 g L-1 for lactate in the range of 0.15-1.19 g L-1 , 0.31 E6 cells mL-1 for VCD in the range of 0.96-5.68 E6 cells mL-1 on test sets. The developed analytical method can be used for cell culture process monitoring during manufacturing and meets the analytical purpose of this study. Further, the influence of the number of batches used for model calibration on model performance was also studied to determine how many batches are needed basically for method development. The proposed Raman analytical method development strategy and considerations will be useful for monitoring of similar bioprocesses.
Collapse
Affiliation(s)
- Xu Yan
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Xiaoxiao Dong
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Yuxiang Wan
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Dong Gao
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Zhenhua Chen
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Ying Zhang
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | | | - Kaifeng Chen
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Jingyu Jiao
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Yan Sun
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Zhuohong He
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Lei Nie
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Xiaohui Fan
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Haibin Wang
- Hisun Biopharmaceutical Co. Ltd., Hangzhou, China
| | - Haibin Qu
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| |
Collapse
|
7
|
Machleid R, Hoehse M, Scholze S, Mazarakis K, Nilsson D, Johansson E, Zehe C, Trygg J, Grimm C, Surowiec I. Feasibility and performance of cross-clone Raman calibration models in CHO cultivation. Biotechnol J 2024; 19:e2300289. [PMID: 38015079 DOI: 10.1002/biot.202300289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2023] [Revised: 10/30/2023] [Accepted: 11/21/2023] [Indexed: 11/29/2023]
Abstract
Raman spectroscopy is widely used in monitoring and controlling cell cultivations for biopharmaceutical drug manufacturing. However, its implementation for culture monitoring in the cell line development stage has received little attention. Therefore, the impact of clonal differences, such as productivity and growth, on the prediction accuracy and transferability of Raman calibration models is not yet well described. Raman OPLS models were developed for predicting titer, glucose and lactate using eleven CHO clones from a single cell line. These clones exhibited diverse productivity and growth rates. The calibration models were evaluated for clone-related biases using clone-wise linear regression analysis on cross validated predictions. The results revealed that clonal differences did not affect the prediction of glucose and lactate, but titer models showed a significant clone-related bias, which remained even after applying variable selection methods. The bias was associated with clonal productivity and lead to increased prediction errors when titer models were transferred to cultivations with productivity levels outside the range of their training data. The findings demonstrate the feasibility of Raman-based monitoring of glucose and lactate in cell line development with high accuracy. However, accurate titer prediction requires careful consideration of clonal characteristics during model development.
Collapse
Affiliation(s)
- Rafael Machleid
- Sartorius Stedim Biotech GmbH, Göttingen, Germany
- Computational Life Science Cluster (CLiC), Umeå University, Umeå, Sweden
| | - Marek Hoehse
- Sartorius Stedim Biotech GmbH, Göttingen, Germany
| | | | | | - David Nilsson
- Computational Life Science Cluster (CLiC), Umeå University, Umeå, Sweden
| | | | | | - Johan Trygg
- Computational Life Science Cluster (CLiC), Umeå University, Umeå, Sweden
- Sartorius Corporate Research, Umeå, Sweden
| | | | | |
Collapse
|
8
|
Romann P, Schneider S, Tobler D, Jordan M, Perilleux A, Souquet J, Herwig C, Bielser JM, Villiger TK. Raman-controlled pyruvate feeding to control metabolic activity and product quality in continuous biomanufacturing. Biotechnol J 2024; 19:e2300318. [PMID: 37897126 DOI: 10.1002/biot.202300318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 09/29/2023] [Accepted: 10/26/2023] [Indexed: 10/29/2023]
Abstract
BACKGROUND Despite technological advances ensuring stable cell culture perfusion operation over prolonged time, reaching a cellular steady-state metabolism remains a challenge for certain manufacturing cell lines. This study investigated the stabilization of a steady-state perfusion process producing a bispecific antibody with drifting product quality attributes, caused by shifting metabolic activity in the cell culture. MAIN METHODS A novel on-demand pyruvate feeding strategy was developed, leveraging lactate as an indicator for tricarboxylic acid (TCA) cycle saturation. Real-time lactate monitoring was achieved through in-line Raman spectroscopy, enabling accurate control at predefined target setpoints. MAJOR RESULTS The implemented feedback control strategy resulted in a three-fold reduction of ammonium accumulation and stabilized product quality profiles. Stable and flat glycosylation profiles were achieved with standard deviations below 0.2% for high mannose and fucosylation. Whereas galactosylation and sialylation were stabilized in a similar manner, varying lactate setpoints might allow for fine-tuning of these glycan forms. IMPLICATION The Raman-controlled pyruvate feeding strategy represents a valuable tool for continuous manufacturing, stabilizing metabolic activity, and preventing product quality drifting in perfusion cell cultures. Additionally, this approach effectively reduced high mannose, helping to mitigate increases associated with process intensification, such as extended culture durations or elevated culture densities.
Collapse
Affiliation(s)
- Patrick Romann
- Institute for Pharma Technology, School of Life Science, University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland
- Research Division Biochemical Engineering, Institute of Chemical Environmental and Bioscience Engineering, Vienna University of Technology, Vienna, Austria
| | - Sebastian Schneider
- Institute for Pharma Technology, School of Life Science, University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland
| | - Daniela Tobler
- Institute for Pharma Technology, School of Life Science, University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland
| | - Martin Jordan
- Biotech Process Science, Merck Serono SA (an affiliate of Merck KGaA, Darmstadt, Germany), Corsier-sur-Vevey, Switzerland
| | - Arnaud Perilleux
- Biotech Process Science, Merck Serono SA (an affiliate of Merck KGaA, Darmstadt, Germany), Corsier-sur-Vevey, Switzerland
| | - Jonathan Souquet
- Biotech Process Science, Merck Serono SA (an affiliate of Merck KGaA, Darmstadt, Germany), Corsier-sur-Vevey, Switzerland
| | - Christoph Herwig
- Research Division Biochemical Engineering, Institute of Chemical Environmental and Bioscience Engineering, Vienna University of Technology, Vienna, Austria
| | - Jean-Marc Bielser
- Biotech Process Science, Merck Serono SA (an affiliate of Merck KGaA, Darmstadt, Germany), Corsier-sur-Vevey, Switzerland
| | - Thomas K Villiger
- Institute for Pharma Technology, School of Life Science, University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland
| |
Collapse
|
9
|
Tanemura H, Kitamura R, Yamada Y, Hoshino M, Kakihara H, Nonaka K. Comprehensive modeling of cell culture profile using Raman spectroscopy and machine learning. Sci Rep 2023; 13:21805. [PMID: 38071246 PMCID: PMC10710501 DOI: 10.1038/s41598-023-49257-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2023] [Accepted: 12/06/2023] [Indexed: 12/18/2023] Open
Abstract
Chinese hamster ovary (CHO) cells are widely utilized in the production of antibody drugs. To ensure the production of large quantities of antibodies that meet the required specifications, it is crucial to monitor and control the levels of metabolites comprehensively during CHO cell culture. In recent years, continuous analysis methods employing on-line/in-line techniques using Raman spectroscopy have attracted attention. While these analytical methods can nondestructively monitor culture data, constructing a highly accurate measurement model for numerous components is time-consuming, making it challenging to implement in the rapid research and development of pharmaceutical manufacturing processes. In this study, we developed a comprehensive, simple, and automated method for constructing a Raman model of various components measured by LC-MS and other techniques using machine learning with Python. Preprocessing and spectral-range optimization of data for model construction (partial least square (PLS) regression) were automated and accelerated using Bayes optimization. Subsequently, models were constructed for each component using various model construction techniques, including linear regression, ridge regression, XGBoost, and neural network. This enabled the model accuracy to be improved compared with PLS regression. This automated approach allows continuous monitoring of various parameters for over 100 components, facilitating process optimization and process monitoring of CHO cells.
Collapse
Affiliation(s)
- Hiroki Tanemura
- Biologics Technology Research Laboratories I, Biologics Division, Daiichi Sankyo Co., Ltd., 2716-1, Aza Kurakake, Oaza Akaiwa, Chiyoda-Machi, Oura-Gun, Gunma, 370-0503, Japan.
| | - Ryunosuke Kitamura
- Biologics Technology Research Laboratories I, Biologics Division, Daiichi Sankyo Co., Ltd., 2716-1, Aza Kurakake, Oaza Akaiwa, Chiyoda-Machi, Oura-Gun, Gunma, 370-0503, Japan
| | - Yasuko Yamada
- Analytical & Quality Evaluation Research Laboratories, Pharmaceutical Technology Division, Daiichi Sankyo Co., Ltd., 1-12-1, Shinomiya, Hiratsuka, Kanagawa, 254-0014, Japan
| | - Masato Hoshino
- Biologics Technology Research Laboratories I, Biologics Division, Daiichi Sankyo Co., Ltd., 2716-1, Aza Kurakake, Oaza Akaiwa, Chiyoda-Machi, Oura-Gun, Gunma, 370-0503, Japan
| | - Hirofumi Kakihara
- Biologics Technology Research Laboratories I, Biologics Division, Daiichi Sankyo Co., Ltd., 2716-1, Aza Kurakake, Oaza Akaiwa, Chiyoda-Machi, Oura-Gun, Gunma, 370-0503, Japan
| | - Koichi Nonaka
- Biologics Division, Daiichi Sankyo Co., Ltd., 2716-1, Aza Kurakake, Oaza Akaiwa, Chiyoda-Machi, Oura-Gun, Gunma, 370-0503, Japan
| |
Collapse
|
10
|
Beattie JW, Rowland-Jones RC, Farys M, Bettany H, Hilton D, Kazarian SG, Byrne B. Application of Raman Spectroscopy to Dynamic Binding Capacity Analysis. APPLIED SPECTROSCOPY 2023; 77:1393-1400. [PMID: 37908083 PMCID: PMC10683347 DOI: 10.1177/00037028231210293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/16/2023] [Accepted: 09/25/2023] [Indexed: 11/02/2023]
Abstract
Protein A affinity chromatography is a key step in isolation of biotherapeutics (BTs) containing fragment crystallizable regions, including monoclonal and bispecific antibodies. Dynamic binding capacity (DBC) analysis assesses how much BT will bind to a protein A column. DBC reduces with column usage, effectively reducing the amount of recovered product over time. Drug regulatory bodies mandate chromatography resin lifetime for BT isolation, through measurement of parameters including DBC, so this feature is carefully monitored in industrial purification pipelines. High-performance affinity chromatography (HPAC) is typically used to assess the concentration of BT, which when loaded to the column results in significant breakthrough of BT in the flowthrough. HPAC gives an accurate assessment of DBC and how this changes over time but only reports on protein concentration, requires calibration for each new BT analyzed, and can only be used offline. Here we utilized Raman spectroscopy and revealed that this approach is at least as effective as both HPAC and ultraviolet chromatogram methods at monitoring DBC of protein A resins. In addition to reporting on protein concentration, the chemical information in the Raman spectra provides information on aggregation status and protein structure, providing extra quality controls to industrial bioprocessing pipelines. In combination with partial least square (PLS) analysis, Raman spectroscopy can be used to determine the DBC of a BT without prior calibration. Here we performed Raman analysis offline in a 96-well plate format, however, it is feasible to perform this inline. This study demonstrates the power of Raman spectroscopy as a significantly improved approach to DBC monitoring in industrial pipelines.
Collapse
Affiliation(s)
- James W. Beattie
- Department of Life Sciences, Imperial College London, London, UK
- Department of Chemical Engineering, Imperial College London, London, UK
| | - Ruth C. Rowland-Jones
- Biopharm Process Research, Medicine Development and Supply, GSK R&D, Stevenage, Hertfordshire, UK
| | - Monika Farys
- Biopharm Process Research, Medicine Development and Supply, GSK R&D, Stevenage, Hertfordshire, UK
| | - Hamish Bettany
- Biopharm Process Research, Medicine Development and Supply, GSK R&D, Stevenage, Hertfordshire, UK
| | - David Hilton
- Biopharm Process Research, Medicine Development and Supply, GSK R&D, Stevenage, Hertfordshire, UK
| | | | - Bernadette Byrne
- Department of Life Sciences, Imperial College London, London, UK
| |
Collapse
|
11
|
Kemmer A, Fischer N, Wilms T, Cai L, Groß S, King R, Neubauer P, Cruz Bournazou MN. Nonlinear state estimation as tool for online monitoring and adaptive feed in high throughput cultivations. Biotechnol Bioeng 2023; 120:3261-3275. [PMID: 37497592 DOI: 10.1002/bit.28509] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Revised: 05/08/2023] [Accepted: 07/11/2023] [Indexed: 07/28/2023]
Abstract
Robotic facilities that can perform advanced cultivations (e.g., fed-batch or continuous) in high throughput have drastically increased the speed and reliability of the bioprocess development pipeline. Still, developing reliable analytical technologies, that can cope with the throughput of the cultivation system, has proven to be very challenging. On the one hand, the analytical accuracy suffers from the low sampling volumes, and on the other hand, the number of samples that must be treated rapidly is very large. These issues have been a major limitation for the implementation of feedback control methods in miniaturized bioreactor systems, where observations of the process states are typically obtained after the experiment has finished. In this work, we implement a Sigma-Point Kalman Filter in a high throughput platform with 24 parallel experiments at the mL-scale to demonstrate its viability and added value in high throughput experiments. The filter exploits the information generated by the ammonia-based pH control to enable the continuous estimation of the biomass concentration, a critical state to monitor the specific rates of production and consumption in the process. The objective in the selected case study is to ensure that the selected specific substrate consumption rate is tightly controlled throughout the complete Escherichia coli cultivations for recombinant production of an antibody fragment.
Collapse
Affiliation(s)
- Annina Kemmer
- Chair of Bioprocess Engineering, Technische Universität Berlin, Berlin, Germany
| | - Nico Fischer
- Chair of Measurement and Control, Technische Universität Berlin, Berlin, Germany
| | - Terrance Wilms
- Chair of Measurement and Control, Technische Universität Berlin, Berlin, Germany
| | - Linda Cai
- Chair of Bioprocess Engineering, Technische Universität Berlin, Berlin, Germany
| | - Sebastian Groß
- Chair of Bioprocess Engineering, Technische Universität Berlin, Berlin, Germany
- wega Informatik (Deutschland) GmbH, Weil am Rhein, Germany
| | - Rudibert King
- Chair of Measurement and Control, Technische Universität Berlin, Berlin, Germany
| | - Peter Neubauer
- Chair of Bioprocess Engineering, Technische Universität Berlin, Berlin, Germany
| | - M Nicolas Cruz Bournazou
- Chair of Bioprocess Engineering, Technische Universität Berlin, Berlin, Germany
- DataHow AG, Dübendorf, Switzerland
| |
Collapse
|
12
|
Nikita S, Mishra S, Gupta K, Runkana V, Gomes J, Rathore AS. Advances in bioreactor control for production of biotherapeutic products. Biotechnol Bioeng 2023; 120:1189-1214. [PMID: 36760086 DOI: 10.1002/bit.28346] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Revised: 02/08/2023] [Accepted: 02/08/2023] [Indexed: 02/11/2023]
Abstract
Advanced control strategies are well established in chemical, pharmaceutical, and food processing industries. Over the past decade, the application of these strategies is being explored for control of bioreactors for manufacturing of biotherapeutics. Most of the industrial bioreactor control strategies apply classical control techniques, with the control system designed for the facility at hand. However, with the recent progress in sensors, machinery, and industrial internet of things, and advancements in deeper understanding of the biological processes, coupled with the requirement of flexible production, the need to develop a robust and advanced process control system that can ease process intensification has emerged. This has further fuelled the development of advanced monitoring approaches, modeling techniques, process analytical technologies, and soft sensors. It is seen that proper application of these concepts can significantly improve bioreactor process performance, productivity, and reproducibility. This review is on the recent advancements in bioreactor control and its related aspects along with the associated challenges. This study also offers an insight into the future prospects for development of control strategies that can be designed for industrial-scale production of biotherapeutic products.
Collapse
Affiliation(s)
- Saxena Nikita
- Department of Chemical Engineering, DBT Centre of Excellence for Biopharmaceutical Technology, Indian Institute of Technology, Hauz Khas, Delhi, India
| | - Somesh Mishra
- Department of Chemical Engineering, DBT Centre of Excellence for Biopharmaceutical Technology, Indian Institute of Technology, Hauz Khas, Delhi, India
| | - Keshari Gupta
- TCS Research, Tata Consultancy Services Limited, Pune, India
| | | | - James Gomes
- Kusuma School of Biological Sciences, Indian Institute of Technology, Hauz Khas, Delhi, India
| | - Anurag S Rathore
- Department of Chemical Engineering, DBT Centre of Excellence for Biopharmaceutical Technology, Indian Institute of Technology, Hauz Khas, Delhi, India
| |
Collapse
|
13
|
Online 2D Fluorescence Monitoring in Microtiter Plates Allows Prediction of Cultivation Parameters and Considerable Reduction in Sampling Efforts for Parallel Cultivations of Hansenula polymorpha. BIOENGINEERING (BASEL, SWITZERLAND) 2022; 9:bioengineering9090438. [PMID: 36134983 PMCID: PMC9495725 DOI: 10.3390/bioengineering9090438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/02/2022] [Revised: 08/15/2022] [Accepted: 09/02/2022] [Indexed: 11/23/2022]
Abstract
Multi-wavelength (2D) fluorescence spectroscopy represents an important step towards exploiting the monitoring potential of microtiter plates (MTPs) during early-stage bioprocess development. In combination with multivariate data analysis (MVDA), important process information can be obtained, while repetitive, cost-intensive sample analytics can be reduced. This study provides a comprehensive experimental dataset of online and offline measurements for batch cultures of Hansenula polymorpha. In the first step, principal component analysis (PCA) was used to assess spectral data quality. Secondly, partial least-squares (PLS) regression models were generated, based on spectral data of two cultivation conditions and offline samples for glycerol, cell dry weight, and pH value. Thereby, the time-wise resolution increased 12-fold compared to the offline sampling interval of 6 h. The PLS models were validated using offline samples of a shorter sampling interval. Very good model transferability was shown during the PLS model application to the spectral data of cultures with six varying initial cultivation conditions. For all the predicted variables, a relative root-mean-square error (RMSE) below 6% was obtained. Based on the findings, the initial experimental strategy was re-evaluated and a more practical approach with minimised sampling effort and elevated experimental throughput was proposed. In conclusion, the study underlines the high potential of multi-wavelength (2D) fluorescence spectroscopy and provides an evaluation workflow for PLS modelling in microtiter plates.
Collapse
|
14
|
Romann P, Kolar J, Tobler D, Herwig C, Bielser JM, Villiger TK. Advancing Raman model calibration for perfusion bioprocesses using spiked harvest libraries. Biotechnol J 2022; 17:e2200184. [PMID: 35900328 DOI: 10.1002/biot.202200184] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2022] [Revised: 07/14/2022] [Accepted: 07/26/2022] [Indexed: 11/09/2022]
Abstract
BACKGROUND Raman spectroscopy has gained popularity to monitor multiple process indicators simultaneously in biopharmaceutical processes. However, robust and specific model calibration remains a challenge due to insufficient analyte variability to train the models and high cross-correlation of various media components and artifacts throughout the process. MAIN METHODS A systematic Raman calibration workflow for perfusion processes enabling highly specific and fast model calibration was developed. Harvest libraries consisting of frozen harvest samples from multiple CHO cell culture bioreactors collected at different process times were established. Model calibration was subsequently performed in an offline setup using a flow cell by spiking process harvest with glucose, raffinose, galactose, mannose, and fructose. MAJOR RESULTS In a screening phase, Raman spectroscopy was proven capable not only to distinguish sugars with similar chemical structures in perfusion harvest but also to quantify them independently in process-relevant concentrations. In a second phase, a robust and highly specific calibration model for simultaneous glucose (RMSEP = 0.32 g/L) and raffinose (RMSEP = 0.17 g/L) real-time monitoring was generated and verified in a third phase during a perfusion process. IMPLICATION The proposed novel offline calibration workflow allowed proper Raman peak decoupling, reduced calibration time from months down to days, and can be applied to other analytes of interest including lactate, ammonia, amino acids, or product titer. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Patrick Romann
- Institute for Pharma Technology, School of Life Sciences, University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland.,Research Division Biochemical Engineering, Institute of Chemical Environmental and Bioscience Engineering, Vienna University of Technology, Vienna, Austria
| | - Jakub Kolar
- Institute for Pharma Technology, School of Life Sciences, University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland.,University of Chemistry and Technology Prague, Prague, Czechia
| | - Daniela Tobler
- Institute for Pharma Technology, School of Life Sciences, University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland
| | - Christoph Herwig
- Research Division Biochemical Engineering, Institute of Chemical Environmental and Bioscience Engineering, Vienna University of Technology, Vienna, Austria
| | - Jean-Marc Bielser
- Biotech Process Sciences, Merck Serono SA (an affiliate of Merck KGaA, Darmstadt, Germany), Corsier-sur-Vevey, Switzerland
| | - Thomas K Villiger
- Institute for Pharma Technology, School of Life Sciences, University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland
| |
Collapse
|
15
|
Graf A, Woodhams A, Nelson M, Richardson DD, Short SM, Brower M, Hoehse M. Automated Data Generation for Raman Spectroscopy Calibrations in Multi-Parallel Mini Bioreactors. SENSORS 2022; 22:s22093397. [PMID: 35591088 PMCID: PMC9099804 DOI: 10.3390/s22093397] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/06/2022] [Revised: 04/20/2022] [Accepted: 04/27/2022] [Indexed: 02/04/2023]
Abstract
Raman spectroscopy is an analytical technology for the simultaneous measurement of important process parameters, such as concentrations of nutrients, metabolites, and product titer in mammalian cell culture. The majority of published Raman studies have concentrated on using the technique for the monitoring and control of bioreactors at pilot and manufacturing scales. This research presents a novel approach to generating Raman models using a high-throughput 250 mL mini bioreactor system with the following two integrated analysis modules: a prototype flow cell enabling on-line Raman measurements and a bioanalyzer to generate reference measurements without a significant time-shift, compared to the corresponding Raman measurement. Therefore, spectral variations could directly be correlated with the actual analyte concentrations to build reliable models. Using a design of experiments (DoE) approach and additional spiked samples, the optimized workflow resulted in robust Raman models for glucose, lactate, glutamine, glutamate and titer in Chinese hamster ovary (CHO) cell cultures producing monoclonal antibodies (mAb). The setup presented in this paper enables the generation of reliable Raman models that can be deployed to predict analyte concentrations, thereby facilitating real-time monitoring and control of biologics manufacturing.
Collapse
Affiliation(s)
- Alexander Graf
- Sartorius Stedim Biotech GmbH, August-Spindler-Straße 11, 37079 Goettingen, Germany;
| | | | - Michael Nelson
- Merck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ 07033, USA; (M.N.); (D.D.R.); (S.M.S.); (M.B.)
| | - Douglas D. Richardson
- Merck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ 07033, USA; (M.N.); (D.D.R.); (S.M.S.); (M.B.)
| | - Steven M. Short
- Merck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ 07033, USA; (M.N.); (D.D.R.); (S.M.S.); (M.B.)
| | - Mark Brower
- Merck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ 07033, USA; (M.N.); (D.D.R.); (S.M.S.); (M.B.)
| | - Marek Hoehse
- Sartorius Stedim Biotech GmbH, August-Spindler-Straße 11, 37079 Goettingen, Germany;
- Correspondence:
| |
Collapse
|
16
|
Graf A, Lemke J, Schulze M, Soeldner R, Rebner K, Hoehse M, Matuszczyk J. A Novel Approach for Non-Invasive Continuous In-Line Control of Perfusion Cell Cultivations by Raman Spectroscopy. Front Bioeng Biotechnol 2022; 10:719614. [PMID: 35547168 PMCID: PMC9081366 DOI: 10.3389/fbioe.2022.719614] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2021] [Accepted: 04/04/2022] [Indexed: 11/13/2022] Open
Abstract
Continuous manufacturing is becoming more important in the biopharmaceutical industry. This processing strategy is favorable, as it is more efficient, flexible, and has the potential to produce higher and more consistent product quality. At the same time, it faces some challenges, especially in cell culture. As a steady state has to be maintained over a prolonged time, it is unavoidable to implement advanced process analytical technologies to control the relevant process parameters in a fast and precise manner. One such analytical technology is Raman spectroscopy, which has proven its advantages for process monitoring and control mostly in (fed-) batch cultivations. In this study, an in-line flow cell for Raman spectroscopy is included in the cell-free harvest stream of a perfusion process. Quantitative models for glucose and lactate were generated based on five cultivations originating from varying bioreactor scales. After successfully validating the glucose model (Root Mean Square Error of Prediction (RMSEP) of ∼0.2 g/L), it was employed for control of an external glucose feed in cultivation with a glucose-free perfusion medium. The generated model was successfully applied to perform process control at 4 g/L and 1.5 g/L glucose over several days, respectively, with variability of ±0.4 g/L. The results demonstrate the high potential of Raman spectroscopy for advanced process monitoring and control of a perfusion process with a bioreactor and scale-independent measurement method.
Collapse
Affiliation(s)
- A. Graf
- Product Development, Sartorius Stedim Biotech GmbH, Göttingen, Germany
| | - J. Lemke
- Corporate Research, Sartorius Stedim Biotech GmbH, Göttingen, Germany
- *Correspondence: J. Lemke,
| | - M. Schulze
- Corporate Research, Sartorius Stedim Biotech GmbH, Göttingen, Germany
| | - R. Soeldner
- Corporate Research, Sartorius Stedim Biotech GmbH, Göttingen, Germany
| | - K. Rebner
- Process Analysis and Technology PA&T, Reutlingen University, Reutlingen, Germany
| | - M. Hoehse
- Product Development, Sartorius Stedim Biotech GmbH, Göttingen, Germany
| | - J. Matuszczyk
- Corporate Research, Sartorius Stedim Biotech GmbH, Göttingen, Germany
| |
Collapse
|